alendronate and Graft Occlusion, Vascular studies

alendronate and Graft Occlusion, Vascular

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.

Research Excerpts

Excerpt	Relevance	Reference
" We hypothesized that a self-suspendable nanoparticulate dosage form, with a minimum amount of expients, could be formulated by complexing the negatively charged alendronate with gallium or gadolinium."	5.34	Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. ( Berger, V; Eisenberg, G; Epstein, H; Gao, J; Golomb, G; Koroukhov, N; Levi, I, 2007)
" We hypothesized that a self-suspendable nanoparticulate dosage form, with a minimum amount of expients, could be formulated by complexing the negatively charged alendronate with gallium or gadolinium."	1.34	Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. ( Berger, V; Eisenberg, G; Epstein, H; Gao, J; Golomb, G; Koroukhov, N; Levi, I, 2007)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Danenberg, HD	1
Golomb, G	2
Groothuis, A	1
Gao, J	2
Epstein, H	2
Swaminathan, RV	1
Seifert, P	1
Edelman, ER	1
Berger, V	1
Levi, I	1
Eisenberg, G	1
Koroukhov, N	1

Studies

Danenberg, HD

Golomb, G

Groothuis, A

Gao, J

Epstein, H

Swaminathan, RV

Seifert, P

Edelman, ER

Berger, V

Levi, I

Eisenberg, G

Koroukhov, N

Other Studies

2 other studies available for alendronate and Graft Occlusion, Vascular

Article	Year
Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation, 2003, Dec-02, Volume: 108, Issue:22 Topics: Alendronate; Animals; Cell Count; Cell Division; Cell Movement; Diet, Atherogenic; Disease Models, A	2003
Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. Journal of controlled release : official journal of the Controlled Release Society, 2007, Feb-26, Volume: 117, Issue:3 Topics: Alendronate; Angiogenesis Inhibitors; Animals; Cell Line; Cell Proliferation; Chemistry, Pharmaceuti	2007

Article

Year

Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.

Circulation, 2003, Dec-02, Volume: 108, Issue:22

Topics: Alendronate; Animals; Cell Count; Cell Division; Cell Movement; Diet, Atherogenic; Disease Models, A

2003

Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats.

Journal of controlled release : official journal of the Controlled Release Society, 2007, Feb-26, Volume: 117, Issue:3

Topics: Alendronate; Angiogenesis Inhibitors; Animals; Cell Line; Cell Proliferation; Chemistry, Pharmaceuti

2007